Nuclear factor-κB: a friend or a foe in cancer?

This publication has 94 references indexed in Scilit:

• NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia
  Nature, 2003
• Syk, a Protein-tyrosine Kinase, Suppresses the Cell Motility and Nuclear Factor κB-mediated Secretion of Urokinase Type Plasminogen Activator by Inhibiting the Phosphatidylinositol 3′-Kinase Activity in Breast Cancer Cells
  Published by Elsevier ,2003
• Constitutive activation of NF-κB in Ki-ras-transformed prostate epithelial cells
  Oncogene, 2002
• Nuclear transcription factor-κB as a target for cancer drug development
  Leukemia, 2002
• Protein Kinase C Induces Motility of Breast Cancers by Upregulating Secretion of Urokinase-Type Plasminogen Activator through Activation of AP-1 and NF-κB
  Biochemical and Biophysical Research Communications, 2002
• NF-κB Activation Mediates Doxorubicin-induced Cell Death in N-type Neuroblastoma Cells
  Published by Elsevier ,2001
• Activators and target genes of Rel/NF-κB transcription factors
  Oncogene, 1999
• A20 Inhibits Cytokine-Induced Apoptosis and Nuclear Factor κB–Dependent Gene Activation in Islets
  The Journal of Experimental Medicine, 1999
• Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA
  Oncogene, 1999
• Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-κB
  Oncogene, 1999